The subgenomic RNAs of the fowl coronavirus infectious bronchitis virus (IBV) form a 3' co-terminal or 'nested' set. The presence of non-contiguous (leader) sequences fused to the 5' termini of murine hepatitis virus mRNAs has been demonstrated using RNase T 1 oligonucleotide mapping and sequencing. The presence of a leader sequence on IBV mRNA A has been demonstrated previously. In this paper the presence of a leader identical to that present on the 5' terminus of IBV mRNA A is demonstrated to be present on the 5' terminus of IBV genomic RNA. This has been achieved by sequencing of primer extension products and cDNA clones containing the genomic leader. Analysis of these clones has revealed the presence of a sequence at the leader/genome-length RNA junction which is closely related to regions of homology identified previously within the genomic RNA sequence at the leader/body junctions of subgenomic RNAs. The implications of this finding for mechanisms of coronavirus RNA synthesis are discussed.
INTRODUCTION
Infectious bronchitis virus (IBV) is a coronavirus which infects the fowl. IBV virions, which are enveloped and pleomorphic, contain three major virus-coded protein structures, the surface projection glycoprotein, the membrane glycoprotein and the nucleocapsid protein (Cavanagh, 1981; . The viral genome is a positive-stranded RNA molecule of approximately 20 kilobases (Stern & Kennedy, 1980b) . Six major polyadenylated viral RNA species (A to F) have been detected in infected cells. RNA A is the smallest and RNA F is of genome length (Stern & Kennedy, 1980 b) . These R NAs form a so-called nested or 3' co-terminal set ( Fig. 1 a) (Stern & Kennedy, 1980a, b) ; in vitro translation studies have demonstrated that three of the RNAs function as messengers coding for virion polypeptides and suggest that each mRNA is translated to give a single major polypeptide. Thus, mRNA A codes for the nucleocapsid polypeptide, mRNA C for the membrane polypeptide and mRNA E for the precursor of the surface projection polypeptides , 1984 .
It was initially believed on the basis of the coding potential of the subgenomic RNAs and the sizes of their translation products that in each case the coding region would lie entirely within those 5' 'unique' terminal sequences of the RNA which were not present in the next smallest RNA. The open reading frames (ORFs) coding for these structural polypeptides have been sequenced (Boursnell et al., , 1985 Binns et al., 1985 a) . These data demonstrate that while the membrane polypeptide ORF lies within the 5' terminal sequences of mRNA C which are not present in the next smallest RNA, RNA B, the spike polypeptide ORF ofIBV Beaudette does in fact overlap to a modest extent the likely 5' terminus of the body of RNA D. The potential for overlap of ORFs also exists in the cases of the mRNAs for putative non-structural polypeptides (B and D). However, no translation products have yet been identified for RNAs B and D Boursnell et al., 1985 b) . The observation that purified genomic RNA is infectious (Lomniczi, 1977; Schochetman et al., 1977) demonstrates that it too can function as an mRNA and it is likely that it encodes the viral RNA-dependent RNA polymerase. The origins of the 5' terminal sequences of coronavirus subgenomic RNAs have been investigated in recent years. RNase T1 oligonucleotide mapping studies of murine hepatitis virus (MHV) mRNAs and genomic RNA had indicated the presence of leader sequences derived from the 5' terminus of the genomic RNA on the 5' termini of the subgenomic RNAs (Spaan et al., 1982; Lai et al., 1983) . Cloning and sequencing work with both IBV and MHV has subsequently provided a more direct demonstration of the fusion of a leader to the body sequences of the subgenomic RNAs Spaan et al., 1983) . Leaders of approximately 60 bases on the 5' end of IBV mRNA A and of approximately 70 bases on MHV mRNA 7 have been found. The fusion to the body sequences occurs at positions expected from the 3' co-terminal set model. The presence of tfie leader sequence at the 5' end of the genome has been confirmed for MHV using primer extension (Lai et al., 1984) .
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Regions of homology present in the genomic RNA at fusion sites accurately located by S1 mapping have been detected in the sequences ofcDNA clones ofIBV genomic RNA . Further regions of homology have been detected at fusion sites predicted from mRNA length measurements and from identification of the ORFs for the membrane and spike polypeptides Binns et al., 1985 a) . Regions of homology of this type have also been detected at predicted fusion sites in MHV genomic RNA (Budzilowicz et al., 1985; Skinner et al., I985; .
Various models have been proposed for coronavirus RNA synthesis based on both sequencing data and studies of the replicative intermediate (RI) , but considerably more information of a variety of kinds is required to discriminate between the possibilities. In this paper, we demonstrate the presence of the leader sequence, found previously on mRNA A, at the 5' terminus of the genomic RNA and describe the isolation and characterization of cDNA clones from the 5' terminus. These data further illuminate features of coronavirus RNA synthesis.
METHODS £~olation oflBVgenomic RNA. IBV strains Beaudette and M41 were grown in l 1-day-old embryonated eggs. Virions were isolated from allantoic fluid and purified by isopycnic centrifugation on sucrose gradients. Viral RNA was purified as described previously ~ Primer extension on genomic and cytoplasmic RNA. Primer extension with a synthetic oligonucleotide primer was carried out as follows. The 15-base oligonucleotide primer (5' ATCTAGCGCAAGGCT 3') complementary to the 3' region of the leader sequence of IBV mRNA A was Y-labelled with [~,-3zP]ATP using polynucleotide kinase and purified as described previously . The labelled primer was used to prime reverse transcription of approximately 10 ~tg of IBV genomic RNA in a volume of 50 ~tl containing 50 mM-KC1, 50 mM-Tris HCI (pH 8.3 at 42 ~C), 10 mi-MgCl2, 10 mi-dithiothreitol, 1 mi-dNTPs and 100 units of avian myeloblastosis virus reverse transcriptase. The reaction mixture was incubated at 42 °C for 30 min. An equal volume of deionized formamide containing 0.03 o/~ xylene cyanol FF, 0.03 °. o bromophenol blue and 20 mM-disodium EDTA was added and the sample heated to 100 °C for 3 min. It was immediately loaded onto a 6°o polyacrylamide sequencing gel and electrophoresed until the xylene cyanol FF was approximately half-way down the gel. The gel was exposed to X-ray film and the single labelled band corresponding to the extended primer was cut from the gel (see Fig. 2 ). The extension of the labelled primer on total cytoplasmic RNA from infected cells was carried out as described above except that the RNA was prepared as described previously .
Sequencing o['the primer extension product. The labelled fragment was eluted from the gel using essentially the technique of Maxam & Gilbert (1980) , except that the elution buffer contained no magnesium acetate, and sequenced as described previously .
Production and screening of eDNA clones Jrom IBV genomie RNA Using random priming. A 'library' of cDNA clones was produced from IBV genomic RNA using random priming with calf thymus DNA oligonucleotides (Binns et al., 1985b) . The oligonucleotides were produced as described by Maniatis et al. (1982) . cDNA synthesis was carried out using the method of Gubler & Hoffman (1983) . Approximately 20 ~g of virion RNA and 100 lag of calf thymus DNA oligonucleotides were used for first strand synthesis in a volume of 50 gl. The cDNA was homopolymer-tailed with dC, annealed with dG-tailed PstIdigested pBR322 and used to transform Eseherichia coli strain LE392 (Maniatis et al., 1982) using the procedure of Hanahan (1983) . Approximately 900 tetracycline-resistant colonies were screened for leader sequences using the oligonucleotide described above as a probe. Colonies were transferred to nitrocellulose filters and probed with the oligonucleotide using a modification of the procedure of Grunstein & Hogness (1975) . Two-hundred ng of the oligonucleotide were 5'-labelled with [7-32p]ATP using polynucleotide kinase . The filters were prehybridized for 2 h at 55 °C in 0.9 M-NaC1, 6 mN-EDTA, 90 mM-Tris-HC1 pH 7.5, 0.5°.o NP40 and 100 gg/ml sonicated, denatured herring sperm DNA. The probe was added and hybridization carried out overnight at 25 c C. The filters were then washed twice at room temperature and twice at 37 °C in 6 x SSC and exposed to flashed Fuji RX X-ray film.
Using oligo(dT) priming. These clones were isolated as described previously . Sequencing ofcDNA clones. PvulI and PstI digests of DNA isolated from putative leader sequence clones were recloned into Sinai-cut, phosphatase-treated M 13rap 10 and PstI-digested M 13mp I 1 respectively. Dideoxy chain termination sequencing (Sanger et al., 1977) was carried out using a 'universal' primer. [~-3sS]dATP was used to label the reactions and the reaction products were analysed on buffer gradient gels (Biggin et al., 1983) . A sonic digitizer (Graf/Bar, Science Accessories Corporation) was used to read sequence data into a BBC model B microcomputer; these data were subsequently analysed on a DEC VAX ! 1/750 using the programs of Staden (1982 Staden ( , 1984 .
RESULTS

Demonstration of a leader sequence at the 5' terminus of lBV Beaudette genomic RNA
The presence of a leader sequence on mRNA A of IBV has been demonstrated previously . The presence of this or a related sequence at the 5' terminus of the genomic RNA has not however been reported. We have therefore studied the extension on genomic RNA of a 5'-labelled oligonucleotide complementary to a region close to the 3' end of the leader present on mRNA A. A single extension product of approximately 50 bases was observed on autoradiographs of urea/polyacrylamide sequencing gels (Fig. 2) . In order to confirm the identity of the product it was extracted from the gel and sequenced using the chemical degradation method of Maxam & Gilbert (1980) (Fig. 2) . The sequence obtained in this way is presented in Fig. 3 . The data demonstrate the presence of a leader sequence on the genomic RNA which is identical over the sequenced region to that present on mRNA A. The data presented in Fig. 2 also demonstrate the presence of the leader sequence on RNAs present in a total cytoplasmic RNA preparation from IBV-infected chick kidney cells. The predominant IBV RNA species present in such preparations are the subgenomic mRNAs (T. D. K. Brown, unpublished; Stern & Kennedy, 1980a) . In this case, as in the case of the primer extension on genomic RNA, the extension products were essentially homogeneous in length and sequence. It is, however, formally possible that IBV subgenomic RNAs other than mRNA A lack the sequence complementary to the primer oligonucleotide sequence and thus do not give rise to extension products. 
Isolation of cDNA clones containing leader sequences
The oligonucleotide used in the primer extension experiment described above was used to probe a library ofcDNA clones obtained using random priming of an IBV M41 genomic RNA preparation. Four colonies giving a positive hybridization signal were identified and characterized further. These clones were designated pM41. L1, pM41. L2, pM41. L3, pM41. L4. Plasmid DN As isolated from cultures of the four colonies were digested with PstI and the digests analysed on a 1.5 ~ agarose gel. The gel was blotted onto nitrocellulose and the filter probed with the oligonucleotide. Hybridization of the oligonucleotide with the insert band confirmed the presence of leader sequences in all four clones. A clone pB.L1 hybridizing with the leader oligonucleotide was isolated from an IBV Beaudette cDNA library in the same way. The isolation of clones containing sequences homologous to the leader present on IBV mRNA A from a cDNA library obtained from a genomic RNA preparation suggests that the clones should contain sequences from the genomic leader sequence demonstrated by the primer extension experiment described above. However, it does not provide definitive evidence of their origin, as clones containing IBV subgenomic mRNA sequences can be isolated at low frequency from cDNA produced from genomic RNA preparations (Binns et al., 1985b) . The origin of the contaminating subgenomic RNAs is unclear. The possibility that the leader-containing clones were derived from subgenomic RNAs was initially eliminated by probing of Southern blots of leader sequence clones with cloned genomic sequences spanning the positions of the 5' termini of the subgenomic RNA bodies. The failure of the leader clones to hybridize with genomic sequences from the A/B, B/C, D/E and E/F junctions indicated that they were indeed derived from the 5' terminus of the genomic RNA. The presence of genomic leader sequences in these clones is confirmed by the sequence data described below.
Sequencing of cDNA clones containing leader sequences
Dideoxy chain termination sequencing of PvuII and PstI digests of the putative genomic leader clones recloned in M 13 vectors was carried out. Sequence data derived from the four IBV M41 leader clones and the IBV Beaudette leader clone are shown in contain the complete or almost complete leader. The sequence 5'-wards of the CT(T/G)AACAA core homology region Binns et al., 1985a ) is identical to that present on IBV M41 mRNA A. It is of interest that this sequence differs slightly from that present on IBV Beaudette mRNA A (Fig. 3) . Comparison of the sequence 3"-wards from the homology region shows no signficant homology with sequences previously demonstrated to lie T-wards of the homology regions of the IBV subgenomic mRNAs A, B, C, D and E Boursnell et al., , 1985b Binns et al., 1985a) . This confirms that the clones are indeed derived from sequences present at the 5' terminus of the genomic RNA. The presence of the core homology region in these clones is therefore of particular interest.
DISCUSSION
The data presented above demonstrate the presence of a leader sequence at the 5' terminus of IBV genomic RNA. The sequence of the genomic leader was found to be the same as that of the mRNA A leader. A genomic RNA leader sequence has previously been demonstrated for MHV by both RNase T1 oligonucleotide analysis and by primer extension techniques (Lai et aL, 1984) . However, our data for IBV did not show the heterogeneity in genomic lcader primer extension products seen with MHV. In particular there was no evidence of bands of a length greater than that of the major extension product characterized as having the same sequence as the mRNA A leader. This homogeneity was also observed in the primer extension products obtained when the leader oligonucleotide was extended on total cytoplasmic RNA from IBV-infected chick kidney cells. The significance of this difference is unclear.
It has been suggestcd on the basis of limited $1 mapping data that part of the homology region from MHV mRNAs 6 and 7 is present at the 3' end of the MHV genomic RNA leader sequence (Baric et aL, 1985) . The data presented here show directly that there is a core region of homology (CTTAACAA) at the 3' end of the gcnomic leader sequence of IBV; this information is important in relation to coronavirus replication in that it demonstrates definitively for the first time that a free leader could contain all or part of this sequence and would thus be capable of base-pairing with the complementary sequences of the intergenic regions of homology found in the negative strand replicative/transcriptional intermediate. This represents a plausible element of a mechanism for specific leader/body fusion. Consideration of the sequences of the regions of homology suggests that differences in base-pairing between the leader homology region and the subgenomic homology regions could not alone account for the differences in abundance of the subgenomic RNAs (assuming that their abundance reflects rate of synthesis) (Fig. 5) . If however the free leader does not contain the region of homology it is unlikely that base-pairing is an important element in the fusion mechanism as there is only a low degree of homology between the leader sequence Y-wards of the genomic region of homology and the intergcnic sequences 5'-wards of the subgenomic regions of homology. In this case the regions of core homology and their flanking sequences might be recognition sites for binding of a leader/polymerase complex.
The finding of the homology region at the 3' end of the genomic leader sequence is consistent with the possibility that the genomic length RNA may be synthesized by a mechanism similar to that for subgenomic RNA synthesis.
The sequence data presented for the 5' termini of both IBV Beaudette and IBV M41 genomic RNAs contain a single, extremely short ORF potentially capable of coding for an 11-amino acid peptide. The ORF has a codon usage similar to that of the IBV surface projection glycoprotein coding region and the sequence context of the putative initiator codon suggests that it could be functional (Kozak, 1983) . It is however clear, given the infectivity of purified IBV RNA, that the genomic RNA must be translated to give an RNA-dependent RNA polymerase and it may well be that this small ORF identified in the 5' terminal sequences is not functional.
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